Literature DB >> 23055562

Infection of vascular endothelial cells with human cytomegalovirus under fluid shear stress reveals preferential entry and spread of virus in flow conditions simulating atheroprone regions of the artery.

Jenny B DuRose1, Julie Li, Shu Chien, Deborah H Spector.   

Abstract

Atherosclerosis is a major pathogenic factor in cardiovascular diseases, which are the leading cause of mortality in developed countries. While risk factors for atherosclerosis tend to be systemic, the distribution of atherosclerotic plaques within the vasculature is preferentially located at branch points and curves where blood flow is disturbed and shear stress is low. It is now widely accepted that hemodynamic factors can modulate endothelial gene expression and function and influence the pathophysiological changes associated with atherosclerosis. Human cytomegalovirus (HCMV), a ubiquitous pathogen, has long been proposed as a risk factor for atherosclerosis. To date, the role of HCMV in atherogenesis has been explored only in static conditions, and it is not known how HCMV infection is influenced by the physiological context of flow. In this study, we utilized a parallel-plate flow system to simulate the effects of shear stresses in different regions of the vasculature in vitro. We found that endothelial cells cultured under low shear stress, which simulates the flow condition of atheroprone regions in vivo, are more permissive to HCMV infection than cells experiencing high shear stress or static conditions. Cells exposed to low shear stress show increased entry of HCMV compared to cells exposed to high shear stress or static conditions. Viral structural gene expression, viral titers, and viral spread are also enhanced in endothelial cells exposed to low shear stress. These results suggest that hemodynamic factors modulate HCMV infection of endothelial cells, thus providing new insights into the induction/acceleration of atherosclerosis by HCMV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055562      PMCID: PMC3503096          DOI: 10.1128/JVI.02244-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation.

Authors:  Geoffrey Kloppenburg; Rick de Graaf; Selma Herngreen; Gert Grauls; Cathrien Bruggeman; Frank Stassen
Journal:  Microbes Infect       Date:  2005-01-27       Impact factor: 2.700

2.  Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.

Authors:  B Bodaghi; M E Slobbe-van Drunen; A Topilko; E Perret; R C Vossen; M C van Dam-Mieras; D Zipeto; J L Virelizier; P LeHoang; C A Bruggeman; S Michelson
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

3.  The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.

Authors:  Elena Isern; Montse Gustems; Martin Messerle; Eva Borst; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor.

Authors:  Barbara Reinhardt; Thomas Mertens; Ulrike Mayr-Beyrle; Hedwig Frank; Anke Lüske; Karina Schierling; Johannes Waltenberger
Journal:  Cardiovasc Res       Date:  2005-04-12       Impact factor: 10.787

5.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.

Authors:  Liliana Soroceanu; Armin Akhavan; Charles S Cobbs
Journal:  Nature       Date:  2008-08-13       Impact factor: 49.962

7.  Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.

Authors:  Mary Susan Burnett; Sarfraz Durrani; Eugenio Stabile; Motoyasu Saji; Cheol W Lee; Tim D Kinnaird; Eric P Hoffman; Stephen E Epstein
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

Review 8.  Functional roles of the human cytomegalovirus essential IE86 protein.

Authors:  M F Stinski; D T Petrik
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

9.  Active cytomegalovirus replication in patients with coronary disease.

Authors:  Sara Gredmark; Lena Jonasson; Djoke Van Gosliga; Jan Ernerudh; Cecilia Söderberg-Nauclér
Journal:  Scand Cardiovasc J       Date:  2007-08       Impact factor: 1.589

10.  RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima.

Authors:  Cecilia Söderberg-Nauclér; Piotr Religa; Monika K Grudzinska; Krzysztof Bojakowski; Joanna Soin; Frank Stassen
Journal:  Herpesviridae       Date:  2010-12-23
View more
  16 in total

1.  Studies on the Contribution of Human Cytomegalovirus UL21a and UL97 to Viral Growth and Inactivation of the Anaphase-Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligase Reveal a Unique Cellular Mechanism for Downmodulation of the APC/C Subunits APC1, APC4, and APC5.

Authors:  Alex Clark; Deborah H Spector
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA.

Authors:  Jean-Philippe Belzile; Thomas J Stark; Gene W Yeo; Deborah H Spector
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 3.  Principles for studying in vivo attenuation of virus mutants: defining the role of the cytomegalovirus gH/gL/gO complex as a paradigm.

Authors:  Jürgen Podlech; Matthias J Reddehase; Barbara Adler; Niels A W Lemmermann
Journal:  Med Microbiol Immunol       Date:  2015-03-18       Impact factor: 3.402

4.  New Methods in Tissue Engineering: Improved Models for Viral Infection.

Authors:  Vyas Ramanan; Margaret A Scull; Timothy P Sheahan; Charles M Rice; Sangeeta N Bhatia
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

5.  Human Cytomegalovirus Replication Is Inhibited by the Autophagy-Inducing Compounds Trehalose and SMER28 through Distinctively Different Mechanisms.

Authors:  Alex E Clark; Maite Sabalza; Philip L S M Gordts; Deborah H Spector
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Trehalose, an mTOR-Independent Inducer of Autophagy, Inhibits Human Cytomegalovirus Infection in Multiple Cell Types.

Authors:  Jean-Philippe Belzile; Maite Sabalza; Megan Craig; Alex Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 7.  Functional annotation of human cytomegalovirus gene products: an update.

Authors:  Ellen Van Damme; Marnix Van Loock
Journal:  Front Microbiol       Date:  2014-05-19       Impact factor: 5.640

8.  Cytomegalovirus infection and atherosclerosis in candidate of coronary artery bypass graft.

Authors:  Habib Heybar; Seyed Mohammad Alavi; Mehdi Farashahi Nejad; Mahmood Latifi
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

9.  Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.

Authors:  Ellen Van Damme; Sarah Sauviller; Betty Lau; Bart Kesteleyn; Paul Griffiths; Andrew Burroughs; Vincent Emery; John Sinclair; Marnix Van Loock
Journal:  J Gen Virol       Date:  2014-10-13       Impact factor: 3.891

10.  Cytotoxicity of CdTe quantum dots in human umbilical vein endothelial cells: the involvement of cellular uptake and induction of pro-apoptotic endoplasmic reticulum stress.

Authors:  Ming Yan; Yun Zhang; Haiyan Qin; Kezhou Liu; Miao Guo; Yakun Ge; Mingen Xu; Yonghong Sun; Xiaoxiang Zheng
Journal:  Int J Nanomedicine       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.